Robby E. Kibbelaar

1.3k total citations
49 papers, 947 citations indexed

About

Robby E. Kibbelaar is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Robby E. Kibbelaar has authored 49 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 14 papers in Hematology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Robby E. Kibbelaar's work include Lymphoma Diagnosis and Treatment (10 papers), Acute Myeloid Leukemia Research (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Robby E. Kibbelaar is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Acute Myeloid Leukemia Research (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Robby E. Kibbelaar collaborates with scholars based in Netherlands, Denmark and United Kingdom. Robby E. Kibbelaar's co-authors include Mels Hoogendoorn, Nic J.G.M. Veeger, J. Han van Krieken, D Bitter-Suermann, Rob Michalides, Hanneke C. Kluin‐Nelemans, Philip M. Kluin, Berend van der Lei, Daphne de Jong and Laura van ‘t Veer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Robby E. Kibbelaar

47 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robby E. Kibbelaar Netherlands 15 390 341 195 179 177 49 947
Jun Takizawa Japan 18 428 1.1× 426 1.2× 191 1.0× 263 1.5× 340 1.9× 75 1.1k
Geraldine Pinkus United States 15 390 1.0× 541 1.6× 169 0.9× 279 1.6× 143 0.8× 25 1.1k
Michihide Tokuhira Japan 22 450 1.2× 394 1.2× 231 1.2× 327 1.8× 220 1.2× 80 1.4k
Shinichi Makita Japan 16 403 1.0× 413 1.2× 125 0.6× 114 0.6× 143 0.8× 78 719
Ana Pilar González Spain 17 524 1.3× 286 0.8× 164 0.8× 258 1.4× 491 2.8× 45 1.0k
Yair Herishanu Israel 20 397 1.0× 447 1.3× 156 0.8× 423 2.4× 410 2.3× 87 1.2k
Friederike Kreisel United States 18 384 1.0× 363 1.1× 337 1.7× 206 1.2× 362 2.0× 61 1.4k
Sha Zhao China 16 578 1.5× 677 2.0× 129 0.7× 124 0.7× 242 1.4× 85 963
Lara Mussolin Italy 20 337 0.9× 610 1.8× 409 2.1× 109 0.6× 240 1.4× 73 1.2k
Pierre Heimann Belgium 16 335 0.9× 180 0.5× 543 2.8× 120 0.7× 143 0.8× 49 1.2k

Countries citing papers authored by Robby E. Kibbelaar

Since Specialization
Citations

This map shows the geographic impact of Robby E. Kibbelaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robby E. Kibbelaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robby E. Kibbelaar more than expected).

Fields of papers citing papers by Robby E. Kibbelaar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robby E. Kibbelaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robby E. Kibbelaar. The network helps show where Robby E. Kibbelaar may publish in the future.

Co-authorship network of co-authors of Robby E. Kibbelaar

This figure shows the co-authorship network connecting the top 25 collaborators of Robby E. Kibbelaar. A scholar is included among the top collaborators of Robby E. Kibbelaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robby E. Kibbelaar. Robby E. Kibbelaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kibbelaar, Robby E., Nic J.G.M. Veeger, Marcel Nijland, et al.. (2025). Patients With Relapsed Large B‐Cell Lymphoma After 12 Months Have a Similarly Poor Prognosis to Those Relapsing Within 12 Months. European Journal Of Haematology. 115(4). 391–402.
2.
3.
Siemes, Claire, Frank G. A. Jansman, Robby E. Kibbelaar, et al.. (2023). Effectiveness of a vitamin D regimen in deficient multiple myeloma patients and its effect on peripheral neuropathy. Supportive Care in Cancer. 31(2). 138–138. 7 indexed citations
4.
Verjans, Robin, Annette H. Bruggink, Robby E. Kibbelaar, et al.. (2021). The Dutch National TissueArchive Portal enables efficient, consistent, and transparent procurement of diagnostic tissue samples for scientific use. Cell and Tissue Banking. 22(4). 727–736. 4 indexed citations
5.
Roon, Eric N. van, et al.. (2021). Patterns of transfusion burden in an unselected population of patients with myelodysplastic syndromes: A population‐based study. Transfusion. 61(10). 2877–2884. 5 indexed citations
6.
Kroes, Johannes A., Petra A.M.J. Scholtens, Claire Siemes, et al.. (2021). High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study. Supportive Care in Cancer. 30(1). 271–278. 14 indexed citations
7.
Driessen, Johanna H. M., Mels Hoogendoorn, Robby E. Kibbelaar, et al.. (2020). No decrease in fracture risk despite 15 years of treatment evolution for multiple myeloma patients: A Danish nationwide case-control study. Bone. 134. 115299–115299. 3 indexed citations
8.
Doorduijn, Jeanette K., Josée M. Zijlstra, Pieternella J. Lugtenburg, et al.. (2020). Bortezomib maintenance after R‐CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial. British Journal of Haematology. 190(3). 385–393. 11 indexed citations
9.
Kibbelaar, Robby E., et al.. (2019). Long‐term recurrence rates of whole specimen intraoperative frozen section analysis in basal cell carcinomas of the face with WIFSA. Journal of Surgical Oncology. 119(7). 903–908. 2 indexed citations
10.
Jong, Kim de, et al.. (2017). Whole specimen intraoperative frozen section analysis. Experience with 1082 basal cell carcinomas. European Journal of Surgical Oncology. 44(1). 157–162. 5 indexed citations
11.
Hoogendoorn, Mels, Eric N. van Roon, Robby E. Kibbelaar, et al.. (2017). No outcome disparities in patients with diffuse large B-cell lymphoma and a low socioeconomic status. Cancer Epidemiology. 48. 110–116. 9 indexed citations
12.
Roon, Eric N. van, Peter Joosten, Robby E. Kibbelaar, et al.. (2017). The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study. European Journal of Clinical Pharmacology. 73(6). 771–778. 5 indexed citations
13.
14.
Moelans, Cathy B., et al.. (2010). Validation of a fully automated HER2 staining kit in breast cancer.. SHILAP Revista de lepidopterología. 32(1-2). 149–55. 11 indexed citations
15.
Balink, Hans, et al.. (2009). High F-18 FDG Uptake in Bone Marrow by Cytokines Secreting Ectopic Mucoepidermoid Carcinoma. Clinical Nuclear Medicine. 34(11). 823–824. 10 indexed citations
16.
Glas, Annuska M., Laurent Knoops, Leonie Delahaye, et al.. (2007). Gene-Expression and Immunohistochemical Study of Specific T-Cell Subsets and Accessory Cell Types in the Transformation and Prognosis of Follicular Lymphoma. Journal of Clinical Oncology. 25(4). 390–398. 197 indexed citations
17.
Visser, Henk, et al.. (1994). Painless cholestatic jaundice in a 77-year-old woman. Annals of Hematology. 68(5). 261–265. 1 indexed citations
18.
Kibbelaar, Robby E., et al.. (1993). Statistical methods in interphase cytogenetics: An experimental approach. Cytometry. 14(7). 716–724. 43 indexed citations
19.
Kibbelaar, Robby E., Rob Michalides, Peter C. Van Bodegom, et al.. (1991). Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. European Journal of Cancer and Clinical Oncology. 27(4). 431–435. 79 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Takizawa Breakdown of academic impact, for papers by Geraldine Pinkus Breakdown of academic impact, for papers by Michihide Tokuhira Breakdown of academic impact, for papers by Shinichi Makita Breakdown of academic impact, for papers by Ana Pilar González Breakdown of academic impact, for papers by Yair Herishanu Breakdown of academic impact, for papers by Friederike Kreisel Breakdown of academic impact, for papers by Sha Zhao Breakdown of academic impact, for papers by Lara Mussolin Breakdown of academic impact, for papers by Pierre Heimann
Rankless by CCL
2026